Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development. The Editors welcome: Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.

《Expert Opinion on Drug Discovery》（ISSN 1746-0441 [印刷版]、1746-045X [电子版]）是 MEDLINE 索引、同行评审的国际期刊，发表有关药物发现过程中涉及的新技术的评论文章，从而产生新的线索并降低流失率。该期刊涵盖领域包括： 涵盖化学信息学的评论； 生物信息学； 检测开发； 新颖的筛选技术； 体外/体内模型； 基于结构的药物设计； 系统生物学； 药物案例历史检查特定药物的临床前和临床开发所涉及的步骤 观众包括医疗保健和制药行业的科学家和管理人员、学术制药科学家和其他密切相关的专业人士，希望通过临床前水平的优化来提高候选药物的成功率。